4
Changes in Ownership
Compass Therapeutics, Inc. Filed Acc 0000947871-22-001164
Director bought 402,000 shares at $3.21 ($1,290,420)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC Director | 2022-11-08 | Purchase | +402,000 | $3.21 | $1,290,420 | 15,219,994 | I |
| Open-market purchases · 402,000 sh · avg $3.21 · $1,290,420 | |||||||
Loading xslF345X03/ownership.xml…